test44
https://www.cytel.com/blog/to-adapt-or-not-to-adapt-a-decision-framework
January 27, 2023
Should your clinical trial be adaptive? Trials that include a prospectively planned modification based on an interim..
Read article
test44
https://www.cytel.com/blog/strategic-clinical-trial-design-unlocks-innovative-funding-opportunity
January 20, 2023
A small biotech’s conventional carcinoma trial design was too expensive to implement and did not offer the opportunity..
Read article
test44
https://www.cytel.com/blog/bayesian-strategies-in-rare-diseases
January 17, 2023
When it comes to rare diseases, a handful of major challenges to drug development arise. Bayesians strategies have..
Read article
test44
https://www.cytel.com/blog/bayesian-methods-across-the-clinical-development-journey
January 13, 2023
Bayesian methods, with their ability to facilitate flexibility and learning, are often associated with early-phase..
Read article
test44
https://www.cytel.com/blog/why-are-there-not-more-bayesian-clinical-trials
January 12, 2023
Statistical methods have long been fundamental to drug development, and advancements in the last few decades in..
Read article
test44
https://www.cytel.com/blog/simulation-guided-design-is-reshaping-clinical-trial-strategy
January 6, 2023
You may have heard that our clinical trial strategy platform Solara® won the Fierce Life Sciences award for Technology..
Read article
test44
https://www.cytel.com/blog/top-perspectives-articles-of-2022
December 29, 2022
Perspectives on Enquiry and Evidence explores a wide variety of topics within clinical trial design and data science in..
Read article
test44
https://www.cytel.com/blog/top-bayesian-topics-of-2022
December 27, 2022
Bayesian methods have been playing a key role in transforming clinical research, providing a variety of new..
Read article
test44
https://www.cytel.com/blog/top-interviews-of-2022
December 21, 2022
Perspectives on Enquiry and Evidence features two recurring interview series: Our new Industry Voices series, in which..
Read article
